1.
Qiu X, Zhang Y, Martin-Rufino JD, et al. Mapping transcriptomic vector fields of single cells. Cell. 2022. doi:10.1016/j.cell.2021.12.045.
Eric Lander
1.
Gupta A, Martin-Rufino JD, Jones TR, et al. Inferring gene regulation from stochastic transcriptional variation across single cells at steady state. Proceedings of the National Academy of Sciences of the United States of America. 2022;119(34):e2207392119. doi:10.1073/pnas.2207392119.
1.
Paranjpe MD, Chaffin M, Zahid S, et al. Neurocognitive trajectory and proteomic signature of inherited risk for Alzheimer’s disease. PLoS genetics. 2022;18(9):e1010294. doi:10.1371/journal.pgen.1010294.
1.
Crowdis J, Balch S, Sterlin L, et al. A patient-driven clinicogenomic partnership for metastatic prostate cancer. Cell genomics. 2022;2(9). doi:10.1016/j.xgen.2022.100169.
1.
Khera A V, Wang M, Chaffin M, et al. Gene Sequencing Identifies Perturbation in Nitric Oxide Signaling as a Nonlipid Molecular Subtype of Coronary Artery Disease. Circulation. Genomic and precision medicine. 2022;15(6):e003598. doi:10.1161/CIRCGEN.121.003598.
1.
Bergman DT, Jones TR, Liu V, et al. Compatibility rules of human enhancer and promoter sequences. Nature. 2022;607(7917):176-184. doi:10.1038/s41586-022-04877-w.
1.
Lennon NJ, Bhattacharyya RP, Mina MJ, et al. Cross-sectional assessment of SARS-CoV-2 viral load by symptom status in Massachusetts congregate living facilities. J Infect Dis. 2021. doi:10.1093/infdis/jiab367.
1.
Collins FS, Schwetz TA, Tabak LA, Lander ES. ARPA-H: Accelerating biomedical breakthroughs. Science. 2021;373(6551):165-167. doi:10.1126/science.abj8547.
1.
Nasser J, Bergman DT, Fulco CP, et al. Genome-wide enhancer maps link risk variants to disease genes. Nature. 2021;593(7858):238-243. doi:10.1038/s41586-021-03446-x.
1.
Cleary B, Simonton B, Bezney J, et al. Compressed sensing for highly efficient imaging transcriptomics. Nat Biotechnol. 2021. doi:10.1038/s41587-021-00883-x.